RIVM_Logo_Engels

Full participation in harm reduction programmes associated with decreased risk for human immunodeficiency virus and hepatitis C virus; evidence from Amsterdam cohort studies among drug users

 

Home / Documents and publications / Full participation in harm reduction programmes associated with decreased risk for human immunodeficiency virus and hepatitis C virus; evidence from Amsterdam cohort studies among drug users

RIVM Committed to health and sustainability
Menu